Biodit AD Statistics

Total Valuation

Biodit AD has a market cap or net worth of BGN 4.02 million. The enterprise value is 4.62 million.

Market Cap	4.02M
Enterprise Value	4.62M

Important Dates

The next estimated earnings date is Monday, April 27, 2026.

Earnings Date	Apr 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Biodit AD has 14.82 million shares outstanding.

Current Share Class	14.82M
Shares Outstanding	14.82M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	68.35%
Owned by Institutions (%)	9.46%
Float	3.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.62
PB Ratio	0.36
P/TBV Ratio	0.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-11.13
EV / Sales	15.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.01, with a Debt / Equity ratio of 0.07.

Current Ratio	4.01
Quick Ratio	0.58
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.83

Financial Efficiency

Return on equity (ROE) is -3.64% and return on invested capital (ROIC) is -1.88%.

Return on Equity (ROE)	-3.64%
Return on Assets (ROA)	-1.87%
Return on Invested Capital (ROIC)	-1.88%
Return on Capital Employed (ROCE)	-3.18%
Weighted Average Cost of Capital (WACC)	6.44%
Revenue Per Employee	36,875
Profits Per Employee	-51,875
Employee Count	8
Asset Turnover	0.02
Inventory Turnover	0.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.84% in the last 52 weeks. The beta is 0.46, so Biodit AD's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	-47.84%
50-Day Moving Average	0.17
200-Day Moving Average	0.36
Relative Strength Index (RSI)	44.51
Average Volume (20 Days)	2,149

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biodit AD had revenue of BGN 295,000 and -415,000 in losses.

Revenue	295,000
Gross Profit	273,000
Operating Income	-368,000
Pretax Income	-415,000
Net Income	-415,000
EBITDA	-270,000
EBIT	-368,000
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 197,000 in cash and 805,000 in debt, giving a net cash position of -608,000 or -0.04 per share.

Cash & Cash Equivalents	197,000
Total Debt	805,000
Net Cash	-608,000
Net Cash Per Share	-0.04
Equity (Book Value)	11.18M
Book Value Per Share	n/a
Working Capital	1.45M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-170,000
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 92.54%, with operating and profit margins of -124.75% and -140.68%.

Gross Margin	92.54%
Operating Margin	-124.75%
Pretax Margin	-140.68%
Profit Margin	-140.68%
EBITDA Margin	-91.53%
EBIT Margin	-124.75%
FCF Margin	n/a

Dividends & Yields

Biodit AD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-10.33%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2